On the other hand, in a murine pancreatic cancer model, the authors found that in tumors overexpressing PDGF-BB, tumor growth was suppressed, and treatment of these tumors with PDGFR inhibitor (imatinib mesylate) resulted in increased growth and decreased total pericyte content [27]. The gene discussed is PDGFRB; the disease is familial pancreatic carcinoma.